Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
CZ Biohub SF LLC is engaged in the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The company currently has 7 pending office actions, reflecting an active pipeline of applications undergoing review. These matters are spread across 5 distinct art units, which indicates that the biological and pharmaceutical innovations cover a variety of specialized technical sub-fields. This spread requires the legal team to navigate the specific examination guidelines of 5 different divisions within the patent office.
There are 7 distinct examiners assigned to these pending actions, ensuring that each action is being reviewed by a different person. The busiest examiner for this portfolio is ELENISTE, PIERRE PAUL, who is currently handling 1 pending office action. The use of 7 examiners across 5 art units suggests a diverse range of expertise is being applied to the portfolio. Practitioners should be prepared to manage multiple simultaneous prosecution tracks, each with its own examiner and technical focus, to move these 7 pending actions toward allowance.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELENISTE, PIERRE PAUL | 1 | 35.5% | +31.2% |
| MOSSBROOK, WILLIAM ERIC | 1 | 53.7% | +75.5% |
| KIM, YOUNG J | 1 | 64.8% | +18.1% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
| GOLDBERG, JEANINE ANNE | 1 | 45.8% | +40.8% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 0.0% | +0.0% |
| WHALEY, PABLO S | 1 | 25.1% | +21.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17923672 | MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS | OGUNTADE, ELIZABETH BISOLA | 70d |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — |
| 18286685 | PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY | GOLDBERG, JEANINE ANNE | — |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838647 | COMPOSITIONS AND METHODS FOR INHIBITING FSP1 | ELENISTE, PIERRE PAUL | — |
| 18835705 | One Gram Penny-Sized Wireless EEG Recording Patch for Long-Term Mental Health Monitoring | MOSSBROOK, WILLIAM ERIC | — |
| 18563307 | METHODS FOR FRAGMENTING COMPLEMENTARY DNA | KIM, YOUNG J | — |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — |
| 18286685 | PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY | GOLDBERG, JEANINE ANNE | — |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| 1681 | 1 |
| 1682 | 1 |
| 1677 | 1 |
| 3619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838647 | COMPOSITIONS AND METHODS FOR INHIBITING FSP1 | ELENISTE, PIERRE PAUL | — | §112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18835705 | One Gram Penny-Sized Wireless EEG Recording Patch for Long-Term Mental Health Monitoring | MOSSBROOK, WILLIAM ERIC | 3794 | §103 | Final Rejection | — | Pending | Aug 02, 2024 |
| 18563307 | METHODS FOR FRAGMENTING COMPLEMENTARY DNA | KIM, YOUNG J | 1681 | §103 | Final Rejection | — | Pending | Nov 21, 2023 |
| 18563310 | METHOD FOR PRODUCING A POPULATION OF SYMMETRICALLY BARCODED TRANSPOSOMES | PARISI, JESSICA DANIELLE | — | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18286685 | PROFILING CELL TYPES IN CIRCULATING NUCLEIC ACID LIQUID BIOPSY | GOLDBERG, JEANINE ANNE | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 17923672 | MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS | OGUNTADE, ELIZABETH BISOLA | 1677 | §103§112Other | Final Rejection | 70d | Pending | Nov 07, 2022 |
| 17768780 | USER INTERFACE AND BACKEND SYSTEM FOR PATHOGEN ANALYSIS | WHALEY, PABLO S | 3619 | §101§103§112 | Non-Final OA | — | Pending | Apr 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial